Pharmaceutical Raw Material Allopurinol CAS 315-30-0 Treating acute lymphoblastic leukemia
Detalles Rápidos:
nombre del producto: Allopurinol
Sinónimos: TIMTEC-BB SBB004202;ISOPURINOL;LABOTEST-BB LT00244764;HPP;1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-OL;AKOS BBS-00005290;ALLPURINOL;AKOS BBS-00002073
CASO: 315-30-0
MF: C5H4N4O
EINECS: 206-250-9
Categorías de Producto:PYRIMIDINE;Miscellaneous Natural Products;Heterocyclic Compounds;Antitumors for Research and Experimental Use;Chemical Reagents for Pharmacology Research;Biochemistry;Nucleobases and their analogs;Nucleosides, Nucleotides & Related Reagents;heterociclos;intermedios & Productos químicos finos;Productos farmacéuticos;Fused Ring Systems;API’s;Miscellaneous Enzyme;Bases & Related Reagents;Nucleotides;ZYLOPRIM;inhibitor;Other APIs
Mp:>300 ° C(Solución antibacteriana necesaria en alcohol bencílico de aceite esteroide)
temperatura de almacenamiento. Room temperature.
Solución antibacteriana necesaria en alcohol bencílico de aceite esteroide:0.35 gramos/litro (25 C)
Merck :279
CAS DataBase Reference:315-30-0(CAS DataBase Reference)
NIST Chemistry Reference:Allopurinol(315-30-0)
EPA Substance Registry System:4H-Pyrazolo[3,4- d]pyrimidin-4-one, 1,5-dihydro-(315-30-0)
Hazard Codes:T,Xi,Xn
Declaraciones de riesgo:25-43-36/37/38-20/21/22
Declaraciones de seguridad:28-36/37-45-36/37/39-26-24-36
RIDADR:UN 2811 6.1/PG 3
WGK Alemania:2
RTECS:UR0785000
HazardClass :6.1
Solicitud:
Allopurinol inhibits the breakdown (catabolism) of the thiopurine drug mercaptopurine, and was specifically invented by Gertrude Elion to enhance the action of mercaptopurine in the treatment of acute lymphoblastic leukemia. Sin embargo, no improvement in leukemia response was noted with mercaptopurine-allopurinol cotherapy, and this use of the drug was abandoned.
Allopurinol is used as an add-on drug for refractory epilepsy, because it is an adenosine agonist, which inhibits glutamine release from excitatory neurons, but does not change the plasma concentration of other epilepsy drugs.
Allopurinol was also commonly used to treat tumor lysis syndrome in chemotherapeutic treatments, as these regimens can rapidly produce severe acute hyperuricemia, although it has gradually been replaced by urate oxidase therapy
embalaje & Delivery Process
1. With sufficient stock, so we can deliver promptly at the very day upon receipt of the payment.
2. Agente logístico sofisticado y profesional. Asumimos la responsabilidad de proporcionar a nuestros clientes una entrega rápida y un envío seguro..
3. Equipo de embalaje bien entrenado y disciplinado. Maneras únicas de enviar 10 gramos a 100 kg de polvos a la vez a su destino. Fast and discreet shipment could be arranged for customs to pass The Guaranteed.
4. Las imágenes de embalaje y el código de tachuelas se proporcionan dentro 12 horas después de recibir el pago. La información de seguimiento actualizada se proporcionará cada dos días..
5. Servicio postventa: Cualquier duda o problema después de recibir el producto, Siéntete libre de contactarnos. Problems would be solved for you immediately.
Gerente de ventas